Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Going Into 2024, PWC Predicts Healthy Atmosphere For M&A

Jan 03 2024

• By Joseph Haas

A man businessman holding hands over a blue glowing plasma sphere. Magic prediction and foresight in business and Finance — PWC anticipates an uptick in deal-making in 2024

Related Content

IRA Implications Will Factor Significantly In Deal Strategy In 2023

Jan 16 2023

BMS Bets $8.4bn On Biokin’s Bispecific ADC

Dec 12 2023

Roche Looks To Muscle Into Obesity Market With $2.7bn Carmot Buyout

Dec 04 2023

Novo Nordisk Looks To Bring AI/ML To Cardiometabolic Disease In Valo Health Deal

Sep 25 2023

Despite Pfizer/Seagen’s Splash, Deals Are Staying Small

Jul 12 2023

Related Companies

Pfizer Inc.

Seagen Inc.

ImmunoGen, Inc.

Bristol Myers Squibb Company

Novo Nordisk A/S

Eli Lilly and Company

Additional Topics

Business Strategies M & A Deals Financing Commercial BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.